Prime Capital Investment Advisors LLC Grows Stake in Humana Inc. (NYSE:HUM)

Prime Capital Investment Advisors LLC grew its position in shares of Humana Inc. (NYSE:HUM) by 36.6% in the fourth quarter, Holdings Channel reports. The firm owned 1,130 shares of the insurance provider’s stock after purchasing an additional 303 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Humana were worth $517,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in HUM. Sunbelt Securities Inc. bought a new stake in shares of Humana during the 1st quarter worth $28,000. Gradient Investments LLC lifted its holdings in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC bought a new stake in shares of Humana during the 3rd quarter worth $39,000. Baystate Wealth Management LLC lifted its holdings in shares of Humana by 84.1% during the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock worth $37,000 after acquiring an additional 37 shares during the last quarter. Finally, Nvwm LLC lifted its holdings in shares of Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after acquiring an additional 25 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on HUM. Royal Bank of Canada dropped their price objective on shares of Humana from $507.00 to $415.00 and set an “outperform” rating for the company in a report on Friday, January 26th. Stephens lowered their price target on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research note on Friday, January 26th. The Goldman Sachs Group lowered their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Raymond James assumed coverage on shares of Humana in a research note on Friday, March 22nd. They issued a “market perform” rating for the company. Finally, UBS Group reissued a “neutral” rating and issued a $370.00 price target (down from $530.00) on shares of Humana in a research note on Friday, January 26th. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $465.42.

Humana Stock Performance

Shares of NYSE:HUM opened at $319.17 on Thursday. The company has a market cap of $38.51 billion, a price-to-earnings ratio of 16.10, a price-to-earnings-growth ratio of 1.86 and a beta of 0.45. The company has a 50-day moving average price of $349.73 and a 200-day moving average price of $431.90. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a 12 month low of $299.23 and a 12 month high of $541.21.

Humana (NYSE:HUM) last announced its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. During the same quarter in the prior year, the firm earned $1.62 EPS. Humana’s quarterly revenue was up 17.9% compared to the same quarter last year. As a group, equities analysts anticipate that Humana Inc. will post 16.02 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Wednesday, March 27th. Humana’s dividend payout ratio is currently 17.86%.

Insider Activity at Humana

In related news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.29% of the stock is owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.